Maria Stepanova

Statin use is not associated with liver related mortality.

A comparative analysis of relative occurrence of transcription factor binding sites in vertebrate genomes and gene promoter areas.

Potential regulatory SNPs in promoters of human genes: a systematic approach.

Contrasting uptake routes and tissue distributions of inorganic and methylmercury in mosquitofish (Gambusia affinis) and redear sunfish (Lepomis microlophus).

Establishing a statistic model for recognition of steroid hormone response elements.

In silico modelling of hormone response elements.

Conformational analysis of the carboxy-terminal tails of human beta-tubulin isotypes.

Dynamics of essential collective motions in proteins: theory.

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

Carnosine [corrected] increases efficiency of DOPA therapy of Parkinson's disease: a pilot study.

Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirin.

Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.

Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.

Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease.

Hepatitis C virus infection, age, and Hispanic ethnicity increase mortality from liver cancer in the United States.

Phosphoproteomic biomarkers predicting histologic nonalcoholic steatohepatitis and fibrosis.

A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.

Oxidative stress induced in rat brain by a combination of 3-nitropropionic acid and global ischemia.

Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.

Association of serum adipocytokines with hepatic steatosis and fibrosis in patients with chronic hepatitis C.

Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS).

Protein pathway activation associated with sustained virologic response in patients with chronic hepatitis C treated with pegylated interferon (PEG-IFN) and ribavirin (RBV).

Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States.

Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality.

Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C.

Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. population.

Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease.

Comparative analysis of essential collective dynamics and NMR-derived flexibility profiles in evolutionarily diverse prion proteins.

Effects of temperature on the p53-DNA binding interactions and their dynamical behavior: comparing the wild type to the R248Q mutant.

African americans are less likely to have clearance of hepatitis C virus infection: the findings from recent U.S. population data.

Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.

The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin.

Conformational modes in biomolecules: dynamics and approximate invariance.

Exploring the essential collective dynamics of interacting proteins: application to prion protein dimers.

In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009.

Nonalcoholic fatty liver disease in lean individuals in the United States.

Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C).

Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease.

Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example.

SML resist processing for high-aspect-ratio and high-sensitivity electron beam lithography.

Recent trends in inpatient mortality and resource utilization for patients with stroke in the United States: 2005-2009.

Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD).

Molecular mechanisms in the activation of abscisic acid receptor PYR1.

Inpatient economic and mortality assessment for liver transplantation: a nationwide study of the United States data from 2005 to 2009.

A new comorbidity model for predicting mortality in patients with cirrhosis: does it work?

Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C.

Minimal impact of sofosbuvir and ribavirin on health related quality of life in Chronic Hepatitis C (CH-C).

Predictors of chronic liver disease in individuals with human immunodeficiency virus infection.

Understanding interactions of functionalized nanoparticles with proteins: a case study on lactate dehydrogenase.

Trends in outpatient resource utilizations and outcomes for medicare beneficiaries with nonalcoholic Fatty liver disease.

Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens.

Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: the VALENCE study.

Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study.

Molecular mechanisms in the selective basal activation of pyrabactin receptor 1: Comparative analysis of mutants.

The portrait of an adult liver transplant recipient in the United States from 1987 to 2013.

Anti-Adipocyte Antibody Response in Patients with Non Alcoholic Fatty Liver Disease.

The outcomes of adult liver transplants in the United States from 1987 to 2013.

Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes.

New mutations in the Notch3 gene in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL).

Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials.

Age-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity.

Ledipasvir/sofosbuvir regimens for chronic hepatits c (chc) infection: insights from a work productivity economic model from the United States.

Association of Sleep Disorders with Nonalcoholic Fatty Liver Disease (NAFLD): A Population-based Study.